ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 on Nivo + Cabo vs. Sunitinib for Advanced RCC: Final OS Analysis and Organ-Specific Target Lesion Assessments w/ 2-Year Follow-Up in CheckMate 9ER
By
ASCO Genitourinary Cancers Symposium
FEATURING
Thomas Powles
By
ASCO Genitourinary Cancers Symposium
FEATURING
Thomas Powles
259 views
March 2, 2022
Login to view comments.
Click here to Login
Videos